GlaxoSmithKline PLC ADR

GlaxoSmithKline PLC ADR

Yahoo Finance • 3 hours ago

Hospital group files lawsuit to stop 340B rebate pilot again

[An overturned pill bottle spills cash and medicinal capsules] Enrique Yocoyani Aguilar Licona/iStock via Getty Images The American Hospital Association has once again filed a lawsuit to halt a new pilot that tests a revised rebate model... Full story

Yahoo Finance • 3 days ago

GSK (LSE:GSK) Deepens Its Drug Pipeline Through Two Research Partnerships

GSK (LSE:GSK) has entered a collaboration with Wave Life Sciences to advance a GalNAc-siRNA hepatology candidate into its development pipeline. The partnership with Wave Life Sciences focuses on RNA-based therapies targeting liver diseases... Full story

Yahoo Finance • 7 days ago

AbbVie, Amgen, Pfizer, GSK among participants in new 340B rebate pilot

The Trump administration has selected 10 companies, including AbbVie (ABBV [https://seekingalpha.com/symbol/ABBV]), Amgen (AMGN [https://seekingalpha.com/symbol/AMGN]), Pfizer (PFE [https://seekingalpha.com/symbol/PFE]), and GSK (GSK [http... Full story

Yahoo Finance • 9 days ago

Abbott Stock And Other Healthcare Dividend Names Built For Supply Chain Shocks

Markets are back to obsessing over central bank signals, supply routes and growth downgrades, and that mix is shaking up how investors look at reliable income. When credit feels tighter and headlines keep flagging disruption risks, steady... Full story

Yahoo Finance • 10 days ago

Pharmaceutical industry lobbying group names new CEO, Eric Cantor

[Cantor And John Thune Hold Press Conference On Economy] Alex Wong/Getty Images News * The Pharmaceutical Research and Manufacturers of America (PhRMA) has selected former Republican House Majority Leader Eric Cantor as its next CEO and... Full story

Yahoo Finance • 10 days ago

Hatteras Venture Partners Names Sir Andrew Witty as Chairman and Ned Sharpless, M.D., as Managing Director of Hatteras Discovery Innovation, Expanding Proven Investment Strategies

Hatteras Venture Partners – Hatteras holds first closing of Hatteras Opportunity Fund II (HOF II) – – HOF II closing brings capital under management to over $1 billion – DURHAM, N.C., Sept. 30, 2026 (GLOBE NEWSWIRE) -- Hatteras Venture... Full story

Yahoo Finance • 11 days ago

CDC data now show two measles deaths for 2026; Pennsylvania records four

[Measles] sefa ozel/iStock via Getty Images The CDC has updated its count of measles cases in the U.S. to indicate two deaths for this year, while Pennsylvania continues to report four measles-linked fatalities amid a dispute with the Hea... Full story

Yahoo Finance • 17 days ago

GSK Targets £40B Sales as Oncology Push and £1.9B Savings Plan Take Shape

Key Points Interested in GSK PLC Sponsored ADR? Here are five stocks we like better. GSK is targeting more than £40 billion in sales, above the £36.4 billion consensus estimate, with oncology assets—including antibody-drug conjugates, BLE... Full story

Yahoo Finance • 18 days ago

AstraZeneca and GSK warn Europe’s drug industry is ‘at risk’

Britain's biggest pharmaceutical companies have warned the future of the industry is at risk as Europe loses ground to the US and China in medical research. AstraZeneca and GSK, along with European rivals Novo Nordisk, Sanofi, Roche and N... Full story

Yahoo Finance • 19 days ago

ALK appoints Tina Abild Olesen as Executive Vice President for Corporate, Portfolio and Product Strategy

ALK Abello Tina A. Olesen, Executive Vice President for Corporate, Portfolio and Product StrategyTina A. Olesen has been appointed Executive Vice President for Corporate, Portfolio and Product Strategy at ALK, effective 1 October 2026. A... Full story

Yahoo Finance • 22 days ago

4 Biotech Stocks to Watch as Potential Takeover Targets

M&A activity in the biotech sector has accelerated sharply in 2026, as large drugmakers increasingly turn to external innovation to strengthen pipelines, expand into new therapeutic areas and gain access to promising technologies and late-... Full story

Yahoo Finance • 23 days ago

Revolut eyes stock market listings in London and New York

Nik Storonksy wants his digital bank to have a presence in Wall Street, not just London - Geoff Pugh Revolut is plotting a dual stock market listing in London and New York. The digital bank, valued at $115bn (£85bn), has previously shied... Full story

Yahoo Finance • 23 days ago

GSK (LSE:GSK) Stock Looks Reasonable As Its 58% Run Continues

GSK has delivered a solid multi year share price run, helped by fresh moves in oncology and vaccines, and that raises a simple question for investors who care about valuation. Is the current price you see on screen today adequately support... Full story

Yahoo Finance • 24 days ago

The West is hooked on Chinese drugs but they could save your life

Sir Keir Starmer's decision to invite Sir Pascal Soriot, AstraZeneca's chief executive, to Beijing at the beginning of the year was a textbook piece of modern diplomacy. The then-prime minister's attempt to revive economic cooperation res... Full story

Yahoo Finance • 25 days ago

GSK Cuts 641 Jobs in Vaccine Manufacturing Restructuring

GSK plc (NYSE:GSK) plans to close its vaccine manufacturing facility in Dresden, Germany, by summer 2027, putting 641 jobs at risk. The decision reflects declining demand for traditional egg-based flu vaccines, which has left GSK with more... Full story

Yahoo Finance • 25 days ago

GSK to Acquire Experimental Blood Cancer Therapy From Chimagen in $750 Million Deal

GSK (GSK) agreed to acquire global rights to an experimental T-cell engager therapy for multiple mye PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 26 days ago

INCY Stock Gains 23% Year to Date: Buy, Sell or Hold?

Shares of Incyte INCY have rallied 23% year to date compared with the industry's growth of 5.2%. The stock has also outperformed the medical sector and the S&P 500 Index during this time frame. Much of this rally came after the company re... Full story

Yahoo Finance • 26 days ago

Biggest stock movers Monday: AI, chip stocks, and more

[Graph background of financial technology stock market business analysis] Donny DBM/iStock via Getty Images Stock futures trade lower early Monday as Brent crude nears $108 a barrel following escalated Middle East tensions and key pipelin... Full story

Yahoo Finance • 29 days ago

High-Grade Monthly: Summer sprint continues post-Labor Day as rates soar

Blazing high-grade issuance for a holiday-shortened week back from Labor Day — a historically explosive period for pent-up dealmaking after summer lulls — totaled $57 billion Tuesday and Wednesday alone across 30 offerings, raising the pos... Full story

Yahoo Finance • 30 days ago

GSK’s mRNA Flu Vaccine Shows Promise, But Can It Deliver Late-Stage?

GSK plc (NYSE:GSK) is advancing its experimental seasonal influenza vaccine into late-stage development after encouraging mid-stage results in both younger and older adults. The mRNA-based candidate generated stronger immune responses tha... Full story